Class 4 Medicines Defect Information: Crescent Pharma Ltd, SyreniRing 0.120 mg/0.015 mg per 24 hours, vaginal delivery system, EL (20)A/36

Crescent Pharma Ltd has warned that the Patient Information Leaflet for the affected batches is missing important safety data relating to the risk of depression in women using hormonal contraceptives.


Medicines and Healthcare products Regulatory Agency